Approval of an Investigational Device Exemption (IDE) submission must occur by the FDA before a manufacturer can begin a (moderate to high risk) clinical investigation of its medical device in the US. Major factors evaluated by the FDA in order to determine approval status of IDE applications include non-clinical testing data, risk assessment and study design elements.